FOXA1 and nasopharyngeal carcinoma: Ammous-Boukhris et al. studied 56 NPC patients and found that FOXA1 expression is present in 60.7% of patients, and this is associated with the TNM stage and age at diagnosis (low TNM and older age at diagnosis).